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ABSTRACT

This article provides a close look at the development of intellectual property
protection contrasted with the development of globalization. Specifically, the
agreements forming the legal framework of the World Trade Organization are
discussed and their impact on the economic development of developing countries
examined. A closer look is given to China and India, where only recently intellectual
property protection standards complying with mandatory rules of the TRIPS
Agreement have been introduced, and where the most remarkable economic,
scientific, and technological development can be observed. This article emphasizes
the necessity of all members of the World Trade Organization to comply with their
obligations under all WTO Agreements, i.e. GATT 1994, TRIPS, TRIMS and GATS,
in order to prevent frictions of international trade.
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INTRODUCTION

Those who have spent decades studying the field of intellectual property
protection will not be particularly surprised by the criticism of the international
system of intellectual property rights protection and of the broad view of these rights,
which has been increasingly vehement.
Even though a widely surprising
breakthrough in support of higher, internationally binding standards of intellectual
property protection could have been achieved with the acceptance of the
International Agreement on Trade Related Aspects of Intellectual Property Rights
("TRIPs") in 1994, TRIPs was at the center of multifaceted criticism, for both
developing and developed countries.1 Indeed, the criticism of the developing nations
soon found support, in part, from internationally recognized economists and lawyers.
It did not go unrecognized, even by the critics, that TRIPs, together with the General
Agreement on Tariffs and Trade ("GATT 1994"), the Agreement on Trade-Related
Investment Measures ("TRIMs"), the General Agreement on Trade in Services
("GATS"), together and with all their appendices, represents only one of the pillars of
support of the international legal system of the World Trade Organization ("WTO").
It also did not go unrecognized that developing countries would only accept TRIPs in
this context in order to secure access to the markets of industrialized countries.
However, it was asserted that ninety percent of all patents are granted in
industrialized states, that TRIPs negotiations are brought to an end without a broad
cost benefit analysis of, for example, welfare-related aspects of intellectual property
rights for less developed countries, and that developing countries and other net
importers of protected knowledge accept TRIPs only on political and not economic
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1 See generally THE SECRETARIAT OF THE WORLD INTELLECTUAL PROPERTY ORGANIZATION,
PROPOSAL BY ARGENTINA AND BRAZIL FOR THE ESTABLISHMENT OF A DEVELOPMENT AGENDA FOR
WIPO, WO/GA/3 1/11, August 27, 2004, availbble at http://www.wipo.org/documents/en/document/
govbody/wo-gb-ga/pdf/wo-ga_31_11.pdf [hereinafter SECRETARIAT].
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grounds. 2 It was further claimed that TRIPs was the result of a strong and
coordinated political lobby of U.S. and European industry, an "aggressive
unilateralism" on the behalf of the United States and the European Communities,
and lacked a necessary legitimacy because it was not based on the concept of human
rights.3 Even Secretary-General of the United Nations, Kofi Annan, admonished that
the progression of free trade and the legal system cannot be taken for granted: "we
must resolve to underpin the free global market with genuinely global values and
secure it with effective institutions. We must show the same firm leadership in
defence of human rights, labour standards, and the environment as we already do in
defence of intellectual property. 4

I. THE NEW WAVE OF TRIPS CRITICISM
It would doubtlessly go too far to attempt even a brief reference to all recent
publications that have critically dealt with the current international concept of
intellectual property rights. However, in the articles of Maskus and Reichman,5
Musungu and Dutfield,6 or those of Boyle,' for instance, it is clear that each of them
in some way questions the current system and calls for a moratorium on
international development of intellectual property rights. These articles suggest that
developing nations be given the possibility either to thoroughly evaluate their realm
of interests on the basis of the newly gained knowledge,' or to impede a possible
cessation of WIPO activities in TRIPs-plus standards, 9 or finally, as seen in Boyle, 0
2 Ernst-Ulrich Petersmann, From Negative to Positive Integration in the WTO. The TRIPs
Agreement and the WTO Constitution, in INTELLECTUAL PROPERTY: TRADE, COMPETITION, AND

SUSTAINABLE DEVELOPMENT 21, 23 (Thomas Cottier & Petros C. Mavroidis eds., The University of
Michigan Press 2000).
3 Id. at 23, 42.
Trade liberalization in the WTO should not only be based on utilitarian objectives
of 'welfare maximization' but also on human rights concepts, such as individual
freedom .... non-discrimination .... and rule of law subject to judicial review by
national courts and international adjudication ....
The time has come for
recognizing that human rights law offers WTO rules moral, constitutional and
democratic legitimacy that may be more important for the parliamentary
ratification of future WTO Agreements than the traditional economic and
utilitarian justifications.
Id. at 44.
Kofi Annan, Laying the Foundationsof a Fairand Free World Trade System, in THE ROLE OF
THE WORLD TRADE ORGANIZATION IN GLOBAL GOVERNANCE 26, 27 (Gary P. Sampson ed., 2001).
5 See generally Keith E. Maskus & Jerome H. Reichman, The Globalization of Private
Knowledge Goods and the Privatizationof Global Public Goods, 7 J. INTL ECON. L. 279 (2004).
6 See generallySISULE F. MUSUNGU & GRAHAM DUTFIEL, MULTILATERAL AGREEMENTS AND A
TRIPS-PLUS WORLD: THE WORLD INTELLECTUAL PROPERTY ORGANIZATION ("WIPO"), available at
http ://www.geneva.quno.info/pdf/WIPO(A4)finaO304.pdf.
7 See generallyJames Boyle, A Manifest on WIPO and the Future of Intellectual Property,
2004
DUKE
L.
&
TECH.
REV.
0009
(2004),
available
at
http://www.law.duke.edu/journals/dltr/articles/PDF/2004DLTROOO9.pdf
[hereinafter Manifest on
WIPO]. See generally James Boyle, The Second Enclosure Movement and the Construction of the
Public Domain, 66 LAW & CONTEMP. PROBS. 33 (2003).
8 Maskus, supra note 5, at 319.
9 MUSUNGU, supra note 6 at 24.
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to call the entire concept of the system into question. These authors neither
entertain the existing circumstances of developing nations and industrialized nations
before TRIPs, 1 nor, even more surprisingly, do they base their theoretical
deliberations on any empirical insights that they could have accumulated in this
matter since the implementation of TRIPs.1 2 Indeed, no single attempt has been
made in this direction. Even the moderately worded paper of the British Commission
on Intellectual Property Rights ("CIPR")13 contained explicit allusions that
"developing countries accepted TRIPs not because at the time the adoption of
intellectual property protection was high on their list of priorities, but partly because
they thought the overall package offered, including the reduction of trade
protectionism in developed countries, would be beneficial." 14 There were complaints
that these expectations had not been rewarded, but the complaints lacked a
reciprocal offering of empirical data. The statistics retrieved from the databanks of
the World Bank, which refer to the alleged benefit of patent licenses, according to
which the active trade balance of the United States rose from fourteen billion U.S.
dollars to over twenty-two billion U.S. dollars between 1991 and 2001,15 prove
nothing about the macroeconomic results of the WTO "Package Deal" on developing
nations.
The comment made by Nobel Prize winner Joseph Stiglitz, that the structure of
intellectual property rights has become so extreme that it is harmful to society and
16
especially harmful to developing countries, points in the same direction.
Institutional mechanisms should be established "so that we can go back and
recognize the need for developing countries, for instance, to have some technology
transfer." 7 Similar, but even more explicit, is the Geneva Declaration on the Future
of the World Intellectual Property Organization of October 2004, signed by Stiglitz,
among others, which accuses WIPO of "embrac[ing] a culture of creating and
expanding monopoly privileges, often without regard to consequence."18
A
moratorium should be made on the negotiations of new treaties and the
harmonization of standards that further strengthen and augment monopolies and
restrict access to knowledge. The Declaration states that WIPO has, for generations,
predominantly reacted "to the narrow concerns of powerful publishers,

10Manifest on WIPQ supranote 7.
11See generally Joseph Straus, Implications of the TRIPS Agreement in the Field of Patent
Law, in FROM GATT TO TRIPS - THE AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL
PROPERTY RIGHTS 160 (Friedrich-Karl Beier & Gerhard Schricker eds., 1996).
12 See, e.g., Petersmann, supra note 2, at 32 35.
13

See

generally

COMMISSION

ON

INTELLECTUAL

PROPERTY

RIGHTS,

INTEGRATING

INTELLECTUAL PROPERTY RIGHTS AND DEVELOPMENT POLICY (2002).

1Id.at 8.
15Id. at 21. The greatest loser in this regard was Korea with fifteen billion U.S. dollars. Id.
61Joseph E. Stiglitz, Globalism Discontents, 13 THE AMERICAN PROSPECT 1 (2002), available at
http ://www.prospect.org/print/V13/1/stiglitz-j.html.
17 See also Interview by Mamudi with Joseph Stiglitz, How to fix the IP Imbalance, in 143
MANAGING INTELLECTUAL PROP. 28 (2004) ("We need to develop the institutional mechanisms so
that we can go back and recognize the need for developing countries, for instance, to have some
technology transfer.").
18 GENEVA DECLARATION
ORGANIZATION (2005),

ON

THE

FUTURE

OF THE

WORLD

INTELLECTUAL

PROPERTY

available at http://www.cptech.org/ip/wipo/futureofwipodeclaration.pdf.
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pharmaceutical manufacturers, plant breeders and other commercial interests. '19
Now it should address the fundamental needs of consumer protection and human
rights: "Long-neglected concerns
of the poor, the sick, the visually impaired and
20
others must be given priority.,
The Argentine and Brazilian recommendation for a "Development Agenda" for
WIP0 2 demands, among other things, that WIPO's role should not be solely limited
to the promotion of intellectual property protection. 22 Treaties in this area should
explicitly take into account the interest of the consumer and of the general public. It
is important that the exceptions and the boundaries of the national law of member
states remain protected.23 Special attention should be paid to the idea of establishing
an international regime, which would provide developing countries with access to
publicly funded research results in industrialized nations. Such a regime could
follow the form of the Treaty on Access to Knowledge and Technology. 24 The
recommendation further demands that the currently negotiated agreements in
WIPO, such as the Substantive Patent Law Treaty ("SPLT"), 25 should include
provisions on technology transfer, competition inhibiting practices, specific clauses on
the principles and goals of the agreements as they are laid down in Articles 7 and 8 of
TRIPs, and ensure the flexibility of public interest. However, these provisions should
only be included with the concurrent clarification that the WIPO agreements "do not
expressly deal with 'trade-related issues.' 26 In other words, Argentina and Brazil do
not want the agreements to contain reference to trade related aspects of intellectual
property.

II. WHAT HAS THE NEW WTO LEGAL SYSTEM REALLY ACHIEVED?
The given goals of the WTO legal system, within which the developing countries
accepted TRIPs as an integral component, depict the liberalization of international
trade and the equal distribution of its benefits throughout the developed and
developing nations. 27 This primarily demands that the markets of developed and
developing countries be equally open to one another. Although it must be observed
that the OECD-states are still far from fully complying with the requirements of the
WTO, especially in the area of agriculture, the most recent balance between
developing and industrialized nations looks positive. 28 The national economies of
19

Id.

20 Id.
21 SECRETARIAT,
22 Id.
23

supra note 1.

at 2.

Id. at 1.

24 See CONSUMER PROJECT ON TECHNOLOGY,

TREATY ON ACCESS To KNOWLEDGE

(2005),

available at http://www.cptech.org/a2k/consolidatedtext-may9.pdf.
25 See the report from PRINZ ZU WALDECK UND PYRMONT, WIPO, STANDING COMMITTEE ON

THE LAW OF PATENTS, TENTH SESSION (2004).
26

Id.

27 Supachai Panitchpakdi, Balancing Competing Interests: The Future Role of the WTO, in
THE ROLE OF THE WORLD TRADE ORGANIZATION IN GLOBAL GOVERNANCE 29 (Gary P. Sampson ed.,

2001).
28 Richard H. Steinberg & Timothy E. Josling, Where the Peace Ends: The Vulnerability of EC
and US Agricultural Subsidies to WTO Legal Challenge, 6 J. INT'L ECON. L. 369, 371-372, 414
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these developing states are growing more quickly than those of the industrialized
nations. Their growth rates are the highest in the last thirty years and three-fifths of
these countries have an average rate of growth that is at least six percent greater
than that of the industrialized states. 29 This holds true especially for the four largest
national economies in the group: China, India, Brazil and Russia. The International
Monetary Fund predicts the highest growth rates in the last thirty years over the
next few years for even the Sub-Sahara Africa region 30 although the traditionally
poor regions of Africa and the Middle East have, until now, been considered losers of
globalization.31
The development of Europe is particularly disappointing by
international comparison, which lost ground not only to Asia, but also to the United
States, in spite of the high-set goals of the Lisbon summit in March of 2000.32
India was one of the most vehement opponents of TRIPs,3 3 and did not join the
Paris Convention until December 7, 1998, 34 despite entering the WTO and TRIPs on
January 1, 1995. Additionally, China was one of the states in which there was no
reason to protect intellectual property because of the lack of effective competition in
the domestic marketplace until the 1980s.35 However, it is important to examine
(2003); see also Straus, Patentschutz durch TRIPs- Abkommen - Ausnahmeregelungen und praktiken und ihre Bedeutung, insbesondere hinsichtlich pharmazeutischer Produkte, Bitburger
Gesprfiche, Jahrbuch 2003, Munich 2003, p. 117 et seq. (124).
29

See Grow Up: Developing Countries are growing at Their Fastest Pace for Decades,

ECONOMIST, Oct. 16, 2004, at 16.
o30
Id.
'3'De Jonquieres, Dealingin Doha, FINANCIAL TIMES, Nov. 6, 2001, at 16.
The developing countries generally have had an increasingly larger share of
the industrialized world's imports, which rose from 15% in 1990 to almost 25% in
2000. Over half of Japan's manufactured imports come from developing countries,
while the share for the United States of America was 45%. In the year 2000
alone, developing countries' exports rose by 15% - three times their GDP growth the best rate of growth in five decades. Likewise, the exports from the 49 least
developed countries rose by 28% in the same year - amounting to around US $34
billion. The developing countries' share of world trade has risen from one-fifth in
the 1970s to one-third, and as per current trends it is likely to grow to well over
half of world trade in the next 25 years.
Incidentally, world exports of
manufactured goods have expanded by 8% annually on an average between 1948
and 2000. For the year 2000, the value of world exports of manufactured goods
from these countries was more than 50 times larger than that in 1948, and while
the ratio of exports in respect of goods and services to the GDP was 8% in 1948, it
had increased to 29.5% in the year 2000 taken at constant 1987 prices.
SHAHID ALIKHAN & RAGHUNATH MASHELKAR, INTELLECTUAL PROPERTY AND COMPETITIVE
STRATEGIES IN THE 21ST CENTURY 34 (International Law Publications 2004).
'32HIGH LEVEL GROUP, FACING THE CHALLENGE: THE LISBON STRATEGY FOR GROWTH AND
EMPLOYMENT 10 (2004), available athttp://ec.europa.eu/growthandjobs/pdf/kok-report-en.pdf.
33 Straus, supranote 11, at 168.
31 Decisions of the EnlargedBoard ofAppeal, 27 ONLINE J. EPO 483, 485-86 (2004), available
at http ://www.european-patent-office.org/epo/pubs/ojOO4/10 04/10 4834.pdf.
'3 See also Zhicun Gao & Clem Tisdell, China's Reformed Science and Technology System: An
Overview and Assessment, 22 PROMETHEUS 311, 321 (2004); William A. Fischer & Maximilian von
Zedtwitz, Chinese R&D: Naissance, Renaissance or Mirage, 34 R&D MGMT. 349, 354 (2004),
available
at
http://www.blackwell-synergy.com/doi/abs/10.11 11/j.1467-9310.2004.00346.x.
Admittedly, China began preparations for a system of intellectual property protection already at the
end of the 1970s, as it prepared to enter the Paris Convention. Guo, TRIPs and Intellectual
Property Protection in the People's Replublie of China, GRUR INT. 1996, 292.
Advanced
development of the system only took place during preparation for and adoption of TRIPs. Id.
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more closely the reasons for China and India's development in the light of the WTO
legal system, notwithstanding the peculiarities of these developing or threshold
countries.
Attention is on the development of China, not only because China is the object of
much current common interest as a rising economic power, but more so because of
the wealth of relevant data on its development. The Chinese State Intellectual
Property Office ("SIPO") recorded 308,487 new patent applications in 2003 (this
number covers all three types of patents: invention patents, design patents, and
utility patents). 6 This represents a 22.1 percent increase in invention patents
compared to 2002. 37 Without being able to examine the origin of these applications
here,38 some of the following figures may speak for themselves: the number of people
employed in the field of research and development ("R&D") rose from 781,000 in 1986
to 1,035,000 in 2002. 39 In this regard, China has surpassed Russia, Japan, and, by
some accounts, even the United States.40 With expenditures of sixty billion U.S.
dollars for R&D, China was already in third place worldwide in 2001, behind only the
United States (with 282 billion U.S. dollars) and Japan (with 104 billion U.S.
dollars), but ahead of Germany (with 54 billion U.S. dollars). 41 As measured by the
gross domestic product ("GDP"), expenditures for R&D rose from point 6 percent in
1996 to 1.3 percent in 2002, having more than doubled in only six years. 42 This is
also demonstrated by the shift of R&D workers from state research institutions to
industry, shown by an increase from 154,000 in 1990 to 351,000 in 1999. 4 3 Industry
in 2001 covered sixty percent of all R&D expenditures. This significantly aided
industry capabilities in optimizing the use of imported technologies, and in asserting
China in international competition.44 Since the late 1990s, European and U.S.
36 See Peter Ganea, Die Neuregelung des chinesisehen Patentrechts,GRUR INT., 686 (2002),
available at http://www.jurion.de/logir/login.jsp?goToUrl=../fachpresse/27003.html&docid=2-27003;

see also Ai, ot. a1, in: China Intellectual Property Law Guide, THE HAGUE 2005, at 15, 001 et seq.
(providing detail on the new Chinese patent system).
'37 Compare SIPO, WHITE PAPER ON THE INTELLECTUAL PROPERTY RIGHTS PROTECTION

IN

CHINA IN 2003 (2004), available at http://www.sipo.gov.cn/sipo Englisblndbg/bps/200406/
t20040603_33986.htm [hereinafter SIPO], with DAVID MICHAEL & KEVIN RIVETTE, FACING THE
CHINA CHALLENGE: USING AN INTELLECTUAL PROPERTY STRATEGY TO CAPTURE GLOBAL ADVANTAGE

7-8 (The Boston Consulting Group 2004) (showing an increase of 100% from 1999 in Exhibit 1).
38 SIPO, supranote 37.
'39SIPO,

supra note 37 (stating after China joined the Patent Cooperation Treaty ("PCT"), the

foreign applications for patents of invention outnumbered domestic applications, but in 2003 the tide
turned again in favor of domestic applications (57,000 domestic vs. 49,000 foreign applications)).
40 See Gao & Tisdell, supra note 35; Maximilian von Zedtwitz, Managing Foreign R&D
Laboratories in China, 34 R&D MGMT. 439, 439 (2004), available at http://www.blackwell
synergy.com/doi/abs/10. 111I/j. 1467-9310.2004.0035 Lx. In 2002, Chinese Foreign Direct Investment
("FDI") amounted to fifty-three billion U.S. dollars, which surpassed the U.S. Oliver Gassmann &
Zheng Han, Motivations and Barriersof Foreign R&D Activities in China, 34 R&D MGMT. 423, 423
(2004), available at http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-9310.2004.00350.x.
This clearly shows the support China received from international investors for entering the WTO in
November 2001. Id.
41 Gassmann & Han, supra note 40.
42 See von Zedtwitz, supra note 40, at 358 (according to OECD statistics in 2003, the
expenditures amounted to sixty-nine billion U.S. dollars); see also Fischer & von Zedtwitz, supra
note 35.
13 See Gao & Tisdell, supranote 35, at 318.
44 Id.
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companies such as Siemens, Philips, Nokia, General Electric, and Motorola, as well
as, Japanese, Korean, and Taiwanese companies had been moving their production
facilities to China. According to some accounts, foreign companies opened 60,000
factories in China between 2000 and 2003, allowing Chinese exports to rise to over
400 billion U.S. dollars in 2003. 45 Von Zedtwitz identified approximately 200 R&D
laboratories that had been established, or were in the process of being established in
China at the beginning of 2004, which corresponds to approximately one fourth of the
foreign investment in the United States during 1998.46 What impressed von Zedtwitz
the most was that these investments were transacted during a period of global
economic instability. 47 His investigation also shows that foreign companies do not
move R&D facilities to China in order to solely research according to local needs.48
Rather, companies move with the express task of developing products and technology
for the global market. 49
Nokia, for example, moved divisions crucial to the
development of its third-generation software from Finland to Hangzhou."
One
reason for the move is supposed to be cost effectiveness; Chinese engineers' salaries
are about a quarter of their U.S. or European counterparts.5 1 Moreover, their high
level of technical competence affected Nokia's decision.52
China's commanding, complex, and almost scary development is doubtlessly
dependent on a range of factors that cannot be explored in depth in this article.
Without a doubt, foreign companies would not have become involved in China, at
least not to this extent, had the goods produced in China not had open access to
global markets, which they did because of the new WTO legal system. Similarly, it is
beyond question that China's entrance into WTO, and further development of its
intellectual property rights protection played a decisive role, despite all of the still
prevalent deficits to TRIPs standards.5 3 Gao and Tisdell note in this context:
Following market reforms and commercialisation, the Chinese Government
started to establish a patent system. This has become the cornerstone of
science and technology development in China, and has enabled China to
participate in the World's Intellectual Property market. In 1983, China

45 See also Men and Machines: Technology and Economics Have Already Revolutionized
Manufaeturing. White-Collar Work Will be Next, ECONOMIST, Jan. 13, 2004, at 5-6.
46 See von Zedtwitz, supra note 40, at 440. According to the data collected by von Zedtwitz,
foreign firms should have established some 400 R&D Centers in China by 2002. Id.
47Id.
4 Id.
49Id. at 441.
50 Id.

Id. at 442.
Id.
Von Zedtwitz researched fifteen European, seventeen U.S., and twelve Japanese
companies, as well as five from other countries, including Nokia, Ericsson, Hoffmann-La Roche,
Tetrapak, Volkswagen, Bayer and Siemens. Id. Gassmann & Han, supranote 40, at 427 (providing
a detailed and exhaustive analysis of the motives of transnational companies establishing R&D
activities in China).
F,3See Can Huang et al., Organization,Programmeand Structure:An Analysis of the Chinese
Innovation Policy Framework, 34 R&D MGMT. 367, 382 (2004), available at http://www.blackwellsynergy.com/doi/abs/10.1111/j.1467-9310.2004.00347.x.
See generally ANDREW C. MERTHA, THE
52

POLITICS OF PIRACY: INTELLECTUAL PROPERTY IN CONTEMPORARY CHINA (2005).
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enacted its patent law. This was the first step in establishing a legal basis
for ownership of intellectual property.5 4
Despite the many great and fundamental differences that exist between China
and India, the two great economies share several notable commonalities in the
context at issue. Although not widely known, it was not until the early 1990s that
India liberalized its economy, 55 started a privatization process, 56 and gradually
adapted its patent legislation to a large extent consistent with TRIPs standards.5
India now possesses a wide and well-structured scientific, technological, and
industrial basis.

58

Production costs in India are also quite low.

59

Foreign direct

investment in India is not quite comparable to China, but in 2001-2002 it rose to 3.91
billion U.S. dollars, indicating an increase of sixty-five percent compared to the
previous year, and earning India a seventh place standing in Foreign Direct
Investment ("FDJ") worldwide. 60 The value of textile and clothing exports amounted
to eleven billion U.S. dollars in 2003, and should climb to fifty billion U.S. dollars by
2010, according to the predictions of the Indian government. 61 These factors, paired
with the especially high qualification of Indian scientists and engineers in the field of
information technology, 62 attracted U.S. companies such as Texas Instruments and
Motorola to Bangalore as early as the 1980s. But significant relocation of U.S. and
European companies in previously unthought-of amounts first occurred in the late
1990s - i.e., already under the aegis of the WTO regime - as Hewlett-Packard,
American Express, Citibank, General Electric, and other companies entered India.
The Indian information technology industry reached a turnover of approximately
63
sixteen billion U.S. dollars in 2003, three-quarters of which resulted from exports.
The yearly turnover is supposed to rise to about fifty billion U.S. dollars by 2008.64
The turnover seen by the company Infosys, one of the largest contractors of IT
services, increased eight-fold in five years, and crossed the one billion U.S. dollar

5 Gao & Tisdell, supranote 35, at 324.
55See Ashok K. Gupta et al., Managingthe Process of Market Orientationby PubliclyFunded
Lahoratories: The Case of CSIR, India, 30 R&D MGMT. 289, 289 (2000), availahle at
http ://www.blackwell-synergy.com/doi/abs/10. 1111/1467-9310.00182.
56 See the brochure "Indien 2003-2004 - Verldssicher Wirtschaftspartner - Attraktives FDI
Gebiet," p. 11 et seq. published by the Ministry of External Affairs of the Indian Government
[hereinafter Indien].
57 Prabuddha Ganguli, IntellectualProperty Rights in Transition, 20 WORLD PAT. INFO. 171,
175 (1998); H. Rajeshwari & D.C. Gabriel, An Indian Summer: Contract Research Heats Up, 166
PAT. WORLD 19, 19 (2004). Last amendments to the Indian Patent Act were passed by the
Parliament on Mar. 22, 2005. Id.
58 Ganguli, supra note 57, at 177.
5 See Edward Luce, India's Investment Climate Brightens, FINANCIAL TIMES (London), Nov.
24, 2004, at 5 (noting production costs are about twenty-five percent less than China; however, the
productivity of a worker in India is about fifty percent less than of one in China).
60 See Indien, supranote 56, at 5-6.
(1 See Id.
62 The Place to Be, ECONOMIST, Nov. 11, 2004, at 8, 10. Every year approximately 300,000
information technology engineers graduate from Indian universities, of those about 30,000-40,000
are highly qualified and in demand from foreign companies such as IBM and Accenture. Id.
63-Id.
64Id.
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boundary in the 2003 financial year.65 Infosys maintains an annual training course
capacity of 4,000 students. 66 The so-called Indian Business Process Outsourcing
Industry ("BPO") makes workers in industrialized nations tremble in fear of losing
their jobs. The growth in productivity in the Indian IT service industry is the highest
worldwide. 67 Almost everything can be made quicker, cheaper and better in India,
claims Nandan Nilekani, the managing director of Infosys. 68 His company managed
to create almost 5,000 new jobs in the year 2004.69 But the Indian IT industry is by
no means the only industry that attracts foreign capital and reasons to create R&D
centers. By achieving TRIPs protection standards in the field of pharmaceutical
patent protection,"0 the wave of outsourcing should also include pharmaceutical R&D,
especially where clinical trials are involved. This should lead to a 200 to 300 million
U.S. dollar drop in development costs per drug. Also, German companies such as
Mucos Pharma or Schering AG have become active in this domain. The Indian
Central Drug Research Institute ("CDRI"), a governmental organization, is actively
involved in contract negotiations and contract design for research projects of foreign
companies.
The already well-developed Indian pharmaceutical industry, with
companies such as Dr. Reddy's, Ranbaxy, Orchid, and Cipla, is increasing investment
in its own R&D,1 while other companies are looking for different methods of
collaboration, such as joint venture, combined distribution, and, most recently,
research contracts. 2 As far as India is concerned, there is no doubt that such
development could not have come about without the WTO regime.

III. WHAT ACCOUNTS FOR TRIPS-PLUS AND TRIPS-MINUS?
When the issue of TRIPs-plus comes up, there are many different perceptions
ensconced in the term that can be only briefly discussed here and only in the context
of patent protection. As has already been alluded to, the endeavors to encourage
greater harmonization of substantive patent law in the form of SPLT, made in the
context of WIPO, were assessed by critics as an attempt to usher in TRIPs-plus
standards, and, thus, to deprive developing countries the room to maneuver that
65 Id.

66 Id.
67 Id.
68 Id.

( Faster, Cheaper, Better, ECONOMIST, Nov. 13, 2004, at 12. The Indian IT industry is
projected to create 2.5 million jobs by 2008. Imam, How Does PatentProtection Help Developing
Countries?, 37 INT'L REV. INTELL. PROP. & COMPETITION. L. 245, 256 (2006). IBM, Microsoft,
Metamove, Oracle, and Sathyam computers have built corporate schools for training in India. Id.
70 See Sreenivasarao Vepachedu & Martha M. Rumore, Patent Protection and the
PharmaceuticalIndustry in the Indian Union, INTELL. PROP. TODAY, Oct. 2004, at 44; Sajeev
Chandran et al., Implications of New PatentRegime on Indian PharmaceuticalIndustry:Challenges
and Opportunities,10 J. INTELL. PROP. RTS. 269, 269 (2005).
71 See Khozem Merchant, Scientists in India Develop Now Cure for TB, FINANCIAL TIMES,

Sept. 7, 2004, at 9. Indian scientists have recently developed the first new medicine for the
treatment of tuberculosis and have submitted patent applications for it not only in India but also in
the U.S. Id. See also Chandran et al., supranote 70, at 278.
72 See Rajeshwari & Gabriel, supranote 57; see also Indien, supra note 56, at 83.
73'See Peter Marsh, A Now Manufacturing Mantra, FINANCIAL TIMES, May 16, 2006, at 8

(stating the current state of Indian service-based manufacturing).
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TRIPs had provided them. In particular, commentators have argued that a second
phase with the aim of establishing the international standard for determining the
scope of protection, which would cover also equivalents, would follow the first phase
of the harmonization of standards for prior art, novelty, utility, inventive step,
enabling disclosure, as well as the patent claims drafting.7 4 Dutfield calls this
process "immoral and 'the last insult to developing countries,"'75 and Reichman has
asked for a moratorium on the process.76 Should these efforts for harmonization in
the framework of WIPO, the supposed results of which could be subsumed under the
term TRIPS-plus, eventually fail, this would harm, rather than benefit, all parties
involved, especially the developing nations. 7 A failure would give the United States,
which already takes part in the negotiations with rather restrained enthusiasm, yet
another reason for the bilateral pursuit of its aims. This pursuit, denoted as TRIPsplus, will lead to a rather one-sided export of American protection standards to
partner nations. However, the results do not coercively have to be so, since the
definitions of specific patentability requirements in SPLT relate vastly to purely
legal/technical aspects that are primarily disputed between the United States and
the rest of the world, and whose solution would not disadvantage developing
countries.79
As it did even before the adoption of TRIPS, the United States has been
following the strategy of imposing high standards for the protection of intellectual
property in bilateral free trade agreements ("FTAs"), which surpass the standards of
TRIPs. This policy concerns FTA agreements with very diverse partners such as
Australia, Bahrain, Chile, Jordan, Morocco, and a string of Central American
countries. The core of "plus" lies primarily in the protection of pharmaceutical
inventions. For instance, the possibility of granting compulsory licensing in the case
of public, non-commercial use is reduced to some cases of national emergency and
behavior restricting competition, which constitutes a deviation from the rules of
TRIPS Article 31.0 Furthermore, the FTAs contain clauses on the exclusivity of
data, which pharmaceutical companies submit to competent authorities for the
purpose of gaining marketing approval for new drugs.81 This protection clearly goes
beyond that of Article 39 paragraph 2 of TRIPs against misuse of data by a third
party. 2 The obligation is particularly far reaching since it does not grant marketing
approval for drugs that are covered by patent claims during the patent term, as well
7 See MUSUNGU & DUTFIELD, supra note 6, at 12. For details of the consultation on a gradual
advancement, see Prinzzu Waldeck und Pyrmont,GRUR Int. 2004, 840 et seq.
75 Soe THIRD WORLD NETWORK, WIPO HAS FAILED IN ITS DEVELOPMENT MISSION, available at
http://www.twnside.org.sg/title2/twr171h.htm (last visited Oct. 1, 2006).
76Id.
77 C. Uunker, Informal Session des Standing Committee on the Law of Patents der WIPO in

Genf von 10. bis 12. April 2006, GRUR Int. (2006).
Cf Prinzzu Waldeck und Pyrmont, supranote 74, at 843.
79[d,
80 Soo, e.g., U.S.-Austl. Free Trade Agreement, U.S.-Austl., art. 17.9(7), May 18, 2004,
available at http://www.ustr.gov/TradeAgreements/Bilateral/AustraliaFTA/FinalText/
SectionIndex.html [hereinafter FTA].
81 See for this problem e.g. in European Law, Gassner, Unterlagenschutz im Europfiischen
Arzneimittelrecht, GRUR Int. 2004, 983 et seq.
78
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as during the patent term extension, if any.83 This is supposed to delay market
access to generic drugs as long as possible. Other obligations touching on intellectual
property relate, for instance, to the general commitment of contracting partners to
reduce differences in their respective national laws. For example, the FTA with
Australia obliges Australia to accept the patentability requirement of utility as
fulfilled only if the latter is "specific, substantial and credible. 84 Thus, Australia has
practically adopted the standards of the Utility Examination Guidelines of the U.S.
Patent and Trademark Office ("USPTO"). Critics of the FTAs, such as Drahos,85 view
this as a strategy of the United States, which wants to impose its own protection
standards worldwide via the most-favored-nation clause of Article 4 of TRIPs-the
contracting parties are bound to apply to all members of the WTO.
There is no room here to delve into the criticism of the U.S. TRIPS-plus strategy.
However, it can basically be assumed that contracting parties apply their own costbenefit analysis prior to signing such agreements. The analysis will without a doubt
be based on actual and anticipated bilateral trade with and without the FTA. In this
context, the Australian government has calculated that the FTA will boost the
Australian economy by six billion dollars in benefits annually.8 6 However, other
Australian institutions estimate the total costs to be fifty billion dollars, and that
there will be a loss of up to 200,000 jobs.87 When trying to decide on a course of
action, the choice was clear to the Australian government, because without an FTA
the country would have to fear or perhaps even suffer economic disadvantages.
Drahos and his fellow authors criticize their government for the FTA encroachment
on Australia's sovereign right to independently price pharmaceuticals by means of
the Pharmaceutical Benefits Scheme ("PBS"), the National Health Act, and the
Pharmaceuticals Benefit Pricing Authority ("PBPA"). Because future decisions of the
PBPA will be reviewed by an independent organization, and because generics will be
available on the market only at a later date, the FTA adds to the increasing cost of
the healthcare system.88 In their crusading attacks, especially against the U.S.
Pharmaceutical Industry,89 Drahos and others misjudge something very
fundamental; the philosophy of the Australian PBS is "driven by the principle of
equity of access" and is based on the consideration that

See, e.g., FTA, supranote 80, art. 17.10.
See FTA, supra note 80, art. 17.9(13). The free trade agreement with Bahrain seems to
contain - in view of the up to now rather poor protection standards in Bahrain - an obligation to
provide patent protection for plant patents and to join the International Union for the Protection of
New Varieties of Plants (UPOV), and to arrange for patent protection for new uses of known
products, including uses for further medical indications. See U.S.-Bahr. Free Trade Agreement,
U.S.-Bahr., May 27, 2004, available at http://www.ustr.gov/TradeAgreements/Bilateral/
BahrainFTA/final texts/ SectionIndex.html.
85 See generally Peter Drahos et al., Pharmaceutieals,Intellectual Property and Free Trade:
The Case of the U.S. -AustraliaFree Trade Agreement, 22 PROMETHEUS 243 (2004) (discussing the
U.S.-Australia free trade agreement).
86 Id. at 244.
87 Id.
83
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88 Id.
89 See,

(2002).
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[AIll Australians have a right of access to needed medicines. Need however,
has a utilitarian dimension. The PBS is not designed to provide medicines
for specific individuals with specific needs.
Rather its purpose is to
maximize the access of community of individuals with limited resources to
essential medicines. To paraphrase Jeremy Bentham, the PBS is all about
the greatest health of the greatest number.9"
The idea that this should be part of the responsibility and the cost of the
companies who effectuate the enormous investments, and the economies whose
healthcare systems have rendered the highest drug prices is indeed very appealing,
and could even be realized if globalization had not reached the level it is at today.
However, this idea might now finally belong to the past, especially when it seems
advisable in the context of the macroeconomic considerations of the state in question.
Surely the Australian government saw this similarly. A country cannot demand
access to the U.S. market for agricultural products and seek cutbacks on U.S.
agricultural subsidies, while at the same time demanding access to medicines
developed within the United States at a lower price than the U.S. population pays.
Needless to say, the idea of the "principle of equity of access" is fundamentally
correct, but Australia, as the world's fifteenth largest national economy, must provide
access for its population with its own financial means, and not at the expense of the
U.S. health care system! For countries whose own resources are insufficient, the
international community of states must come to their aid. 9 Here, it should be clearly
stated that this should not be taken as a comment on the appropriateness of drug
prices. Rather, no one should lose sight of, nor compromise the high level of
investments that are admittedly plagued by high risks upon which the continuous
flow of new medicine is dependent and upon which humans are ultimately
dependent.
In summary, it can be observed that the FTAs with TRIPs-plus standards
should only be accepted if they are justified in a macroeconomic context on the basis
of specific provisions of the concerned agreements, and not just on vague hopes. The
term "macroeconomic" can, of course, never be reduced to an isolated examination of
the genuine effects of, e.g., patent protection, but applies to the exact circumstances
of the economies affected, both with and without the FTA. On the current level of
development of globalization, every attempt to disconnect matters of intellectual
property protection from matters of international trade must inevitably fail. If it
ever actually came to pass, it would have negative and lasting effects on
international trade.
Regarding the idea of TRIPs-minus, it should be observed that the development
since the Doha WTO Ministerial Conference in November 2001 has brought about a
TRIPs-minus for the least developed countries, in the respect that they are not
required to start providing patent protection for pharmaceuticals until
January 1, 2016.92 Since the decision of the WTO General Council of August 30,
2003, it has been further clarified that under specific conditions deviating from
Article 31(f) of TRIPs, compulsory licenses can be issued for the production of
90 Drahos, supra note 85, at 244.
91 See Straus, supra note 28, at 132.
92 See

Straus,Bitburger Gespr~che, Jahrbuch 2003, p. 126 ot seq.
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pharmaceuticals in order to satisfy the demands of third-party countries.93
Furthermore, developing countries were advised to completely exclude from
patentability diagnostic, therapeutic, and surgical methods for the treatment of
humans and animals; plants and animals, in a narrower interpretation of the term
microorganism; computer programs; and business methods.94 The countries were
further advised to avoid patenting new uses of known products, the use of the patent
system to protect plant species, and, when possible, genetic material. 95 The countries
of the Andean Community, and with them Argentina and Brazil, have specifically
barred biological material from patent protection, even if isolated from its natural
environment and commercially applicable, and have, thus, adopted standards that
can be seen as TRIPs-minus-standards. 96 Disregarding that some of these measures,
in part recommended and in part already introduced into law, could possibly provide
grounds for a WTO dispute settlement action, they are also not in the wellunderstood interest of the developing nations, and thus stand in clear contradiction
to their own argument. For example, developing countries like Brazil and India
claim, and are by all means justified in doing so, that they should be able to
adequately participate in the commercial gains achieved through the use of their
genetic resources, so-called "benefit sharing." Although, in view of the ability of
biological material to reproduce, it cannot be questioned that such material can be
effectively protected as genotypes, i.e., over generations and also outside the territory
of origin, and thus commercialized profitably for the country of origin only in the
form of patents or other intellectual property rights. 97 These countries exclude the
material in question from patent protection and raise objections against its patent
protection in industrialized countries. As Boyd, Kerr and Perdikis98 stress, the
developing nations at hand concentrate exclusively on the alleged costs of the
respective exclusive rights and thus overlook the benefits of innovation, which
domestic experts as well as foreign companies and research institutions could bestow
upon a nation. 99 Boyd, Kerr and Perdikis accurately note:
Thus, the real question is not how to prevent multinational biotechnology
firms from exploiting developing countries, but rather, how to induce them
to want to exploit developing countries. Multinationals lining up to extract
monopoly rents from developing countries would be the surest sign that
93 See Implementation of Paragraph 6 of the DOHA Declaration on the TRIPS Agreement and
Public
Health,
WT/L/540
and
Corr.
1
(Sept.
1,
2003),
available
at
http://www.wto.org/english/tratop-e/trips-e/implem-para6_e.htm; see also PRESS RELEASE, WTO
NEWS: 2003 NEWS ITEMS, THE GENERAL COUNCIL CHAIRPERSON'S STATEMENT (Aug. 30, 2003),

http://www.wto.org/english/news-e/news03_e/trips-stat-28aug03-e.htm.
91 COMMISSION ON INTELLECTUAL PROPERTY RIGHTS, INTEGRATING INTELLECTUAL PROPERTY
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96See Joseph Straus, Patents on Biomatorial:A Now Colonialism or a Moans for Technology
Transfer and Benefit-Sharing?, in BIOETHICS IN A SMALL WORLD 45, 59 (F. Thiele and R. Ashcroft

eds., 2005).
97Id. at 67.
98 Shari L. Boyd et al., AgriculturalBiotechnology Innovations Versus Intellectual Property
Rights':Are Developing Countriesat the Mercy of Multinational?,4 J. WORLD INV. 211, 212 (2003).
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investments in the desired innovations are taking place. Unless developing
countries or aid-givers are willing to subsidize biotechnology tailored to
developing countries - and there is no evidence to suggest they will - the
investment will simply not take place. The key lies in developing countries'
willingness to extend and enforce IPR's biotechnology. 10
It is beyond question that China acts according to °this advice, and is therefore
able to achieve convincing, even envy-inspiring success.1 1

IV. CLOSING REMARKS AND FURTHER PROSPECTS
Eleven years after the WTO Global Economic Order was established, with GATT
1994 and TRIPs as its main pillars, everyone should realize that international trade,
with open and opening markets, is tightly linked to the international system of
intellectual property protection. Due to the already achieved level of globalization,
GATT 1994 and TRIPs have become practically inseparable. If the achieved status,
which, as empirical data shows, has brought mostly advantages for the developing
countries, and their further development are not to be endangered, every attempt to
disjoin intellectual property protection from the development of international trade
should cease. In view of the effects of globalization on job markets, particularly felt
in industrialized nations on account of job loss from the displacement of production
and R&D to threshold and developing countries, the benefits of globalization for the
national economies of the industrialized countries are not easily communicable, 102
especially as their interests are not always congruent with the interests of
internationally active businesses. Attempts to overturn the laboriously achieved
balance, which by all means benefits the developing countries, could produce a
boomerang effect in favor of those in industrial nations who already want to betake
themselves to protectionism and isolationism no matter how incorrect the latter may
be from an objective point of view.0 3 It is easy to envision what this would mean for
100Id.
101Richard McGregor, China's Success Inspires Envy and Awe, FINANCIAL TIMES, May 28,
2004, at 12.
102 For more on this complicated problem
see Streek, Globalisierung: Mythos und
Wirklichkeit, in Max-Planck-Gesellschaft (ed.), Jahrbuch 2004, Munich 2004, p. 25.
Anders als im Mythosder Globalisierung unterstellt, kann dabei von einem
Bedeutungsverlust staatlicher Politik keine Rede sein. Sektorale Spezialisierung
erfordert im Gegenteil eine integrierte, auf den Ausbau vorhandener
komparativer Vorteile hin mal3geschneiderte national Wirtschafts-, Struktur,
Sozial und Bildungspolitik. Sie verlangt ferner angepasst institutionelle
Regelwerke, etwa fiir den Arbeitsmarkt, die eine optimale Nutzung der
nationalen Ressourcen zugunsten der jeweiligen Kernsektoren ermdglichen.
Id. at 31. See also Into the Unknown: Where Will the Jobs of the Future Come From?, ECONOMIST,
Nov. 13, 2004, at 12; Sink or Swim: Sourcing from Low-cost Countries Works Only in Open and
Flexible Markets. Europe' are Neither, ECONOMIST, Nov. 13, 2004, at 14.
10: See A World of Opportunity: Why the Protectionistsare Wrong, ECONOMIST, Nov. 13, 2004,
at 12. Lawrence H. Summers stated recently in this context:
The twin arguments that globalization is inevitable and protectionism is counterproductive
for almost everyone have the great virtue of being correct - but they do not provide much
consolation for the losers.
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countries such as Bangladesh, Cambodia, Macao, or Pakistan, who make sixty to
eighty percent of their exports with textiles and clothing, and are already fully
exposed to the overpowering competition from China and India as a result of the
abolition of quota regulations on December 31, 2004. 104
The critics of TRIPs are unwilling or unable to accept this. Just as little as
critics considerations reflect the actual state of the developing economies in the preTRIPs era, they do not bear in mind the actual development under the influence of
the WTO system. The expressed criticism rather commemorates the criticism and
the suggestions made by the United Nations Conference on Trade and Development
("UNCTAD") in the seventies of the last century, 15 which inhibited the further
development of the international system for the protection of intellectual property
rights, without having brought the slightest advantage for developing countries,
except for dubious political victories. 106 Even if all comparisons were flawed, the
numerous submitted recommendations for the alteration and amelioration of the
current international system of intellectual property protection in general, in the
interest of the developing countries, in particular, reminds us of Karl Popper's
remark regarding the Freudian psychoanalysis: "Its logical content surely is great;
but its empirical content is zero."10'7 Those who believe they can conceive the
protection of intellectual property rights internationally isolated from the issues of
international trade, misjudge the reality of globalization, its legal foundations, and
its functional machinery. In the current state of the development of globalization,
the compliance with all WTO requirements, i.e., GATT and TRIPs, is decisive to
avoid frictions in international trade, which inevitably would hurt the weaker and
the weakest. WIPO would be well advised to take this to heart. Lately, requests
WIPO has been beset with misjudge these realities and are overwhelming not just for
WIPO, but to the entire system of intellectual property rights protection by
demanding it provide solutions to all the world's problems.
Thus, for the time being, the successful functioning of the international
protection of intellectual property rights in the context of the global economic order
depends on the WTO members' compliance with TRIPs, GATT, TRIMS, and GATS
commitments. TRIPs-minus standards based on the Doha model should remain a
one-time exception, as they only distort and weaken the system without being able to
provide permanent and appropriate solutions to the problems approached.0 8 As far
Lawrence H. Summers, GlobalizationAnxiety, LOS ANGELES TIMES, October 30, 2006, available at
http ://www.latimes.com/news/opinion/la-oe -summers30oct3O, 0,1998395.story?coll=la-opinionrightrail.
104See The Looming Revolution: China, the worlt's works-hop, is poised to become its tailor.
What will happen to textile industries elsewhere, especially in South Asia? ECONOMIST, Nov. 13,
2004, at 76.
105 UNCTAD, THE ROLE OF THE PATENT SYSTEM IN THE TRANSFER OF TECHNOLOGY TO

DEVELOPING COUNTRIES, Doc. TD/B/AC/11/19, April 21, 1974.
106 See on this critically Straus, Patent Protection in Developing countries, an Overview, in:
Equitable Patent Protection for the Developing World, Cornell Agricultural Economic Staff Paper
89-36, Ithaca, NY.
107 "Ihr logischer Gehalt ist sicher gro3; aber ihr empirischer Gehalt ist Null." Popper,
Wissenschaftslehre in entwicklungstheoretischer und in logischer Sicht, in: Popper,Alles Leben ist
Probleml6sen - Uber Erkenntnis, Geschichte und Politik, Munich and Zurich 2004, p. 15 et seq. (41).
108 See Straus, Bitburger Gespr5che, Jahrbuch 2003, p. 129 et seq; see also Glenn Hubbard,
Attacking DrugMakers is no Cure, FINANCIAL TIMES, June 16, 2004, at 15.
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as the real TRIPs-plus deliberations are concerned, they lack the foundation as a
general concept, until a balance in other areas of the WTO economic order can be
achieved, i.e., as long as further concessions concerning market access, possible
investment, etc., are not in place. However, efforts for harmonization in the area of
technical law should be a different matter. Obstruction of, for example, the work of
SPLT, is counterproductive and misguided, especially as several generally
acknowledged weaknesses in the system could also be remedied in this context."19

109See A PATENT SYSTEM FOR THE 21ST CENTURY 49 (Stephen A. Merrill et al., eds., National
Academies Press 2004).

